WASHINGTON - Eligible Medicare beneficiaries can now obtain certain anti-obesity medications for $50 a month under a new ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a ...

The Medicare GLP-1 Bridge Program has opened and will remain open through 2027, giving some Medicare beneficiaries greater ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...

The Centers for Medicare & Medicaid Services launched the Medicare GLP-1 Bridge program, an initiative designed to test the impact of increased access to GLP-1 drugs for weight management among ...

The Centers for Medicare & Medicaid Services July 1 launched the Medicare GLP-1 Bridge, a short-term demonstration program designed to provide eligible Medicare Part D beneficiaries with access to ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of ...

(NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that Weight Watchers Med+ will support Medicare members seeking access to GLP-1 medications under ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Centers for Medicare and Medicaid Services (CMS) announced a ...